Related Experiment Video
Updated: May 19, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
Cancer-Associated Stroke Complicated by Heparin-Induced Thrombocytopenia: A case report
Takashi Okada1, Fumio Miyashita1, Takato Hiramine1
1Department of Neurology and Stroke, Kagoshima City Hospital, Japan.
None:
We present the case of a 74-year-old woman with a large ovarian tumor who developed cancer-associated stroke with multiple acute cerebral infarcts and markedly elevated D-dimer levels. Unfractionated heparin was initiated. However, thrombocytopenia and rising D-dimer levels on Day 11 led to its discontinuation and a diagnosis of probable heparin-induced thrombocytopenia, supported by a strongly positive PF4/heparin antibody assay. Despite subsequent non-heparin anticoagulation, she developed recurrent ischemic stroke and systemic embolic events, and surgery for the ovarian tumor was no longer feasible. This case highlights the therapeutic dilemma posed by the coexistence of cancer-associated stroke and immune-mediated heparin-induced thrombocytopenia.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Stroke: Introduction and Types

